By expenditures
| Name | Title | Type |
|---|---|---|
| Vickie Sayre | Vice President Of Finance & Administration/Cfo | Auditee |
| Kim McGill | Vice President of Finance & Administration/CFO | Auditee |
| Joel Wilkins | AVP/CONTROLLER | Auditee |
| Adam Smith | PARTNER | Auditee |
| Jackson Magdy | SENIOR MANAGER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 381635 | 2025 | 2026-01-14 | FORVIS MAZARS LLP | $47.42M |
| 334614 | 2024 | 2024-12-23 | Forvis Mazars LLP | $47.24M |
| 300140 | 2023 | 2024-03-28 | Forvis LLP | $47.32M |
| 43595 | 2022 | 2022-12-01 | Forvis LLP | $51.47M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 300140 | 2023 | 2024-03-28 | 964849 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 964848 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 964847 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 964846 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 964845 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 964844 | 2023-001 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 964843 | 2023-001 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 964842 | 2023-001 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 964841 | 2023-001 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 388407 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 388406 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 388405 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 388404 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 388403 | 2023-002 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 388402 | 2023-001 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 388401 | 2023-001 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 388400 | 2023-001 | Significant Deficiency | - | N |
| 300140 | 2023 | 2024-03-28 | 388399 | 2023-001 | Significant Deficiency | - | N |